Archives
All entries, chronologically...
Researchers investigating UK samples have found no association between the controversial xenotropic murine leukaemia virus-related virus (XMRV) and chronic fatigue syndrome (CFS). Their study, published in BioMed Central’s open access journal Retrovirology, calls into question a potential link described late last year by an American research team. Check the end of this review for a link to download a PDF of the freely available original study.
Kate Bishop from the MRC National Institute for Medical Research worked with a team of researchers to test blood and serum samples from 170 patients with CFS and 395 healthy controls, using quantitative PCR and a virus neutralization assay. She said, “No association between XMRV infection and CFS was observed in the samples tested, either by PCR or serological methodologies. Our findings therefore appear inconsistent with the previous report that isolated XMRV from the blood cells of CFS patients. We are confident that, although we were unable to replicate the detection, our PCR assay is more sensitive than the earlier method and possessed the necessary sensitivity to detect XMRV had it been present”.
Bishop and her colleagues point out that CFS likely encompasses a range of diseases, and it is still possible that some of them might be associated with XMRV infection. They say, “There has been much discussion and controversy amongst CFS researchers and patients alike, which highlights the need for additional investigations in this area. Following our findings, it would seem a prudent next step for subsequent studies to compare samples and protocols between different laboratories around the world”.
The findings of this Retrovirology study are supported by results from a recently published work from Imperial College London that also found no proof that XMRV infection is associated with CFS.
Material adapted from BioMed Central by CFisher.
Dr. Christopher Fisher, Managing Editor for The Behavioral Medicine Report, received his PhD in Clinical Health Psychology & Behavioral Medicine with an emphasis in biopsychosocial approaches to health and wellness, Cognitive Behavioral Therapy (CBT), neurofeedback, biofeedback, cranial electrical stimulation (CES), and QEEG from University of North Texas. He is Board Certified in Neurofeedback (BCIA). Dr. Fisher also received a master’s degree in Clinical Psychology from Texas A&M-Corpus Christi. Dr. Fisher maintains a private practice in Corpus Christi, Texas, and offers individual therapy, group therapy, and neurofeedback. You can learn more here: http://www.christopherfisherphd.com Dr. Fisher enjoys spending time with family, watching sports and movies, and bicycling on rugged terrain.
Atypical Antipsychotic More Effective Than Older Drugs In Treating Childhood Mania, But Side Effects Can Be Serious
Caffeine Consumption Linked To Estrogen Changes
Sleep Problems Increase Risk For Cardiovascular Disease, Diabetes and Obesity
Deep Brain Stimulation For Parkinson's Improves Motion and Mood And Reduces Medications
FDA Urges Parents To Read Infant Acetaminophen Labels CarefullyAll entries, chronologically...